Prosecution Insights
Last updated: November 20, 2026
Application No. 19/150,032

BALLOON-BASED DEVICE FOR CREATING INTERATRIAL SHUNT

Non-Final OA §102§103
Filed
Jul 22, 2025
Priority
Jan 23, 2023 — provisional 63/481,134 +1 more
Examiner
GUERRERO ROSARIO, ANA VERUSKA
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Inc.
OA Round
1 (Non-Final)
44%
Grant Probability
Moderate
1-2
OA Rounds
2y 8m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allowance Rate
28 granted / 63 resolved
-25.6% vs TC avg
Strong +47% interview lift
Without
With
+46.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
39 currently pending
Career history
122
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
52.0%
+12.0% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
16.5%
-23.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 63 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions REQUIREMENT FOR UNITY OF INVENTION As provided in 37 CFR 1.475(a), a national stage application shall relate to one invention only or to a group of inventions so linked as to form a single general inventive concept (“requirement of unity of invention”). Where a group of inventions is claimed in a national stage application, the requirement of unity of invention shall be fulfilled only when there is a technical relationship among those inventions involving one or more of the same or corresponding special technical features. The expression “special technical features” shall mean those technical features that define a contribution which each of the claimed inventions, considered as a whole, makes over the prior art. The determination whether a group of inventions is so linked as to form a single general inventive concept shall be made without regard to whether the inventions are claimed in separate claims or as alternatives within a single claim. See 37 CFR 1.475(e). When Claims Are Directed to Multiple Categories of Inventions: As provided in 37 CFR 1.475 (b), a national stage application containing claims to different categories of invention will be considered to have unity of invention if the claims are drawn only to one of the following combinations of categories: (1) A product and a process specially adapted for the manufacture of said product; or (2) A product and a process of use of said product; or (3) A product, a process specially adapted for the manufacture of the said product, and a use of the said product; or (4) A process and an apparatus or means specifically designed for carrying out the said process; or (5) A product, a process specially adapted for the manufacture of the said product, and an apparatus or means specifically designed for carrying out the said process. Otherwise, unity of invention might not be present. See 37 CFR 1.475 (c). Restriction is required under 35 U.S.C. 121 and 372. This application contains the following inventions or groups of inventions which are not so linked as to form a single general inventive concept under PCT Rule 13.1. In accordance with 37 CFR 1.499, applicant is required, in reply to this action, to elect a single invention to which the claims must be restricted. Group I, claims 1-14 are drawn to an apparatus Group II, claims 15-20 are drawn to a method The groups of invention listed above do not relate to a single general inventive concept under PC Rule 13.1 because, under PCT 13.2, they lack the same or corresponding special technical features for the following reasons: Groups I and II lack unity of invention a posteriori because even though the inventions of these groups require the technical features of an inflatable balloon and a plurality of electrical conductors, these features are not a special technical feature as it does not make a contribution over the prior art in view of Zarins (US 20080255642 A1) who discloses an inflatable balloon (304) and a plurality of electrical conductors (306 a’, 306 b’) (pa. 0064, 0086 & Fig. 8B). Applicant is reminded that upon the cancelation of claims to a non-elected invention, the inventorship must be corrected in compliance with 37 CFR 1.48(a) if one or more of the currently named inventors is no longer an inventor of at least one claim remaining in the application. A request to correct inventorship under 37 CFR 1.48(a) must be accompanied by an application data sheet in accordance with 37 CFR 1.76 that identifies each inventor by his or her legal name and by the processing fee required under 37 CFR 1.17(i). The examiner has required restriction between product and method claims. Where applicant elects claims directed to the product/apparatus, and all product/apparatus claims are subsequently found allowable, withdrawn method claims that include all the limitations of the allowable product/apparatus claims should be considered for rejoinder. All claims directed to a nonelected process invention must include all the limitations of an allowable product/apparatus claim for that process invention to be rejoined. In the event of rejoinder, the requirement for restriction between the product/apparatus claims and the rejoined method claims will be withdrawn, and the rejoined process claims will be fully examined for patentability in accordance with 37 CFR 1.104. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of 35 U.S.C. 101, 102, 103 and 112. Until all claims to the elected product/apparatus are found allowable, an otherwise proper restriction requirement between product/apparatus claims and method claims may be maintained. Withdrawn process claims that are not commensurate in scope with an allowable product/apparatus claim will not be rejoined. See MPEP § 821.04. Additionally, in order for rejoinder to occur, applicant is advised that the method claims should be amended during prosecution to require the limitations of the product/apparatus claims. Failure to do so may result in no rejoinder. Further, note that the prohibition against double patenting rejections of 35 U.S.C. 121 does not apply where the restriction requirement is withdrawn by the examiner before the patent issues. See MPEP § 804.01. During a telephone conversation with Nihal Parkar on 10/05/2026 a provisional election was made without traverse to prosecute the invention of Group I, claims 1-14. Affirmation of this election must be made by applicant in replying to this Office action. Claims 15-20 are withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to a non-elected invention. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-4, 7, 9-10, and 13-14 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Zarins (U.S. Application No. 20080255642 A1). Regarding independent claim 1, Zarins discloses a medical device (700) comprising: an elongated support member (302) (pa. 0086 & Fig. 8B); an inflatable balloon (304) at a distal portion of the elongated support member (pa. 0064-0065, 0086); and a plurality of electrical conductors (combination of proximal electrode 306 a’, distal electrode 306 b’, and a plurality of extensions) (pa. 0086-0087, 0081) extending longitudinally along the balloon, the plurality of conductors configured to deliver electrical energy to an atrial septum of a patient (pa. 0053, 0065), the electrical conductors being radially spaced apart from one another to form a multicuspid opening in the atrial septum by delivery of the electrical energy (see Fig. 8B). Regarding claim 2, Zarins discloses wherein the electrical conductors lie along an outer surface of the inflatable balloon, extending from a distal end of the inflatable balloon to a proximal end of the inflatable balloon (See Fig. 8B). Regarding claim 3, Zarins discloses wherein when the balloon is inflated the electrical conductors are configured to lie apart from a distal surface of the balloon such that the electrical conductors do not contact a portion of the distal surface of the balloon (See Fig. 8B). Regarding claim 4, Zarins discloses wherein when the balloon is inflated the electrical conductors are configured to lie apart from a proximal surface of the balloon such that the electrical conductors do not contact a portion of the proximal surface of the balloon (See Fig. 8B). Regarding claim 7, Zarins discloses wherein the electrical conductors comprise a flexible material (pa. 0083) such that the electrical conductors expand in a radial direction when the inflatable balloon is inflated (pa. 0079, 0086). Regarding claim 9, Zarins discloses wherein the inflatable balloon is a cryoablation balloon configured for cryoablating tissue with a cryogenic agent (pa. 0136). Regarding claim 10, Zarins discloses wherein the inflatable balloon is configured to be at least partially filled with a cooling agent for cooling surrounding blood or tissue when the electrical conductors are energized (pa. 0066). Regarding claim 13, Zarins discloses wherein the elongated support member comprises a guidewire lumen extending through its length such that the elongated support member can be guided via a guidewire (G) (pa. 0082 & Fig. 8B). Regarding claim 14, Zarins discloses wherein the plurality of electrical conductors are each insulated along their length (via non-conductive connectors 318), being at least partially exposed at one or both of a distal surface of the inflatable balloon or a proximal surface of the inflatable balloon (pa. 0086). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 5-6 and 11 are rejected under 35 U.S.C. 103 as being unpatentable over Zarins as applied to claim 1 above, and further in view of Yang (U.S. Application No. 20220370120 A1). Regarding claim 5, Zarins discloses a guidewire (G) extending through the elongated support member (pa. 0082 & Fig. 8B). However, Zarins does not disclose a puncturing element at a distal tip of the elongated support member, the puncturing element configured to puncture the atrial septum. Yang, in the same field of endeavor, teaches an elongated support member (112) with a guidewire (132) extending through, wherein the guidewire is configured to function as a puncturing element configured to puncture through tissue of a patient to enable advancement of the elongated support member through the tissue (pa. 0043 & Fig. 1A). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the guidewire of Zarins to function as a puncturing element, as described by Yang, in order to enable advancement of the elongated support member through the tissue. Regarding claim 6, Zarins discloses wherein at least one of the electrical conductors extends to a distal tip of the elongated support member (see Fig. 8B), as well as a guidewire (G) extending through the elongated support member (pa. 0082 & Fig. 8B). However, Zarins does not disclose wherein the at least one of the electrical conductors is configured to provide electrical energy to the distal tip for puncturing the atrial septum. Yang, in the same field of endeavor, teaches an elongated support member (112) with a guidewire (132) extending through, wherein the guidewire is configured to function as a puncturing element configured to puncture through tissue of a patient to enable advancement of the elongated support member through the tissue. Specifically, the guidewire may be a conductor and may be configured to be electrified and/or heated (pa. 0043 & Fig. 1A). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the guidewire of Zarins to function as a conductive puncturing element that can be electrified and/or heated, as described by Yang, in order to enable advancement of the elongated support member through the tissue. Examiner notes that the resultant combination yields at least one of the electrical conductors (a combination of proximal electrode 306 a’, distal electrode 306 b’, and a plurality of extensions as already set forth in independent claim 1, as well as the modified guidewire of Zarins which is now configured to be electrified and/or heated) to extend to a distal tip of the elongated support member and be configured to provide electrical energy to the distal tip for puncturing the atrial septum. Regarding claim 11, Zarins discloses wherein the plurality of electrical conductors consists of electrical conductors radially spaced apart (see Fig. 8B). However, Zarins does not disclose wherein the plurality of electrical conductors consists of three electrical conductors radially spaced apart by about 120º such that the multicuspid opening is a tri-leaflet opening. Yang, in the same field of endeavor, teaches expandable members (124) (analogous to the electrical conductors of Zarins) may be circumferentially positioned about elongated support member (112) every 120 degrees, e.g., three expandable members may be evenly spaced about elongated member such that multi-cuspid valvular shunt is formed (pa. 0059). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the number and the spacing of the electrical conductors of Zarins to be three electrical conductors radially evenly spaced apart by about 120º, as taught by Yang, for the purpose of forming a multi-cuspid valvular shunt. Claim 12 is rejected under 35 U.S.C. 103 as being unpatentable over Zarins as applied to claim 1 above, and further in view of Bloom (U.S. Application No. 20150045787 A1). Regarding claim 12, Zarins discloses wherein the plurality of electrical conductors consists of electrical conductors radially spaced apart (see Fig. 8B). However, Zarins does not disclose wherein the plurality of electrical conductors consists of four electrical conductors radially spaced apart by about 90º such that the multicuspid opening is a four-leaflet opening. Bloom, in the same field of endeavor, teaches electrodes (106) that are spaced apart by 90 degrees from one another around the circumference of an inner catheter (102) (pa. 0024 & Fig. 2A). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the number and the spacing of the electrical conductors of Zarins to be four electrical conductors radially evenly spaced apart by about 90º, as taught by Bloom, for the purpose of forming a multicuspid opening with a four-leaflet opening. Allowable Subject Matter Claim 8 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: regarding claim 8 the Zarins (U.S. Application No. 20080255642 A1) reference fails to teach the medical device of claim 8 as a whole. The Zarins reference discloses a medical device (700) comprising an elongated support member (302) (pa. 0086 & Fig. 8B), an inflatable balloon (304) (pa. 0064-0065, 0086), and a plurality of electrical conductors (pa. 0086-0087, 0081). While other embodiments of Zarins, such as Figures 8A or 9E, disclose proximal and distal balloons separated by a portion of the elongated support member, which could be interpreted as a distal lobe and a proximal lobe with a waist between the distal lobe and the proximal lobe, none of the embodiments of Zarins teach wherein the electrical conductors are configured to expand in a radial direction away from the waist when tension is applied to the electrical conductors. Other pertinent art found not previously cited in prior Office Actions include DeSimone (US 20180296264 A1), Kapur (US 20130274728 A1), and Wittenberger (US 20020007180 A1). DeSimone teaches a device with a proximal and distal balloon with a middle portion in between (Figs. 2 and 12). The middle portion is configured to radially expand and longitudinally extend (pa. 0047). However, DeSimone is completely silent on the exact mechanisms that drives such expansion of the middle portion; therefore, it is unclear if the middle portion experiences any tension in order to expand. Kapur teaches an apparatus with a proximal and distal balloons with a conductive mesh extending in between (Figs. 4A-4B), wherein the conductive mesh is coupled to the proximal and distal balloons (pa. 0025). However, the mesh is not configured to actually expand, but rather is lifted or moved radially, and does not experience any tension forces. Lastly, Wittenberger teaches a medical device with proximal and distal balloons with an expansion chamber extending between (see Figs. 3-5). However, the chamber is coupled the balloons and is expanded when the balloons are inflated with a fluid. Therefore, Wittenberger is similarly deficient and does not teach all the limitations of claim 8. Therefore, there is no motivation (either in these references or elsewhere in the art) for making such specific and significant modifications thereto to arrive at claim 8. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Anderson (US 20140018794 A1) teaches systems for nerve modulation. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANA VERUSKA GUERRERO ROSARIO whose telephone number is (571)272-6976. The examiner can normally be reached Monday - Thursday 7:00 - 4:30 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at (571) 272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.V.G./Examiner, Art Unit 3794 /Ronald Hupczey, Jr./Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Jul 22, 2025
Application Filed
Nov 04, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758152
Contact Quality System and Method
4y 9m to grant Granted Oct 13, 2026
Patent 12721535
PULSE TRANSIT TIME MEASUREMENT DEVICE AND BLOOD PRESSURE MEASUREMENT DEVICE
5y 6m to grant Granted Sep 01, 2026
Patent 12667415
BASKET CATHETER WITH CLOVERLEAF STRUCTURE TO PROVIDE PREDETERMINED LATERAL STIFFNESS AND AXIAL STRAIN
3y 3m to grant Granted Jun 30, 2026
Patent 12642574
MEDICAL INSTRUMENT CUTTING SYSTEMS AND METHODS
5y 1m to grant Granted Jun 02, 2026
Patent 12622738
MEDICAL DEVICES AND RELATED METHODS
4y 11m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
44%
Grant Probability
91%
With Interview (+46.7%)
4y 0m (~2y 8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 63 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month